Latest News in the pharma Industry
Top Stories
Evotec Receives Milestone Payment for Ion Channel Project
28 Jun 2011
This project was initiated in October 2009 and the two firms will continue this research collaboration until April 2012.
Read more
Evotec and Roche Ink Biomarker Oncology Pact
27 Jun 2011
Under the initial three-year term, Evotec and Roche will conduct multiple biomarker programs for therapeutic antibodies or small molecule inhibitors.
Read more
BioMarin To Acquire Pfizer Bulk Biologics Plant
27 Jun 2011
BioMarin will acquire a bulk biologics manufacturing plant from Pfizer for $48.5 million. The deal is expected to close around September.
Read more
Boehringer Ingelheim and Ashoka to Launch 'Making More Health' Initiative
27 Jun 2011
The initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenge health problems.
Read more
Fujifilm and Mitsubishi in Bio-CMO Pact
24 Jun 2011
Fujifilm and Mitsubishi have signed an agreement for biopharma contract manufacturing.
Read more
Endo Pharma Acquires AMS for $2.9Bn
24 Jun 2011
Endo Pharmaceuticals Holdings Inc. said Monday it completed its $2.9 billion purchase of American Medical Systems Inc., a leading pelvic-health device provider.
Read more
Australia to Subsidise 13 New Drugs
24 Jun 2011
More than 400,000 Australians will benefit from 13 subsidised medicines from September.
Read more
Sanofi Inks Research Deal with Audion
20 Jun 2011
Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.
Read more
Lundbeck to Submit Alcoholism Drug for European Approval
20 Jun 2011
Lundbeck expects to file its alcoholism drug nalmefene in Europe following positive results from the final trial in the drug's Phase III clinical programme.
Read more
UNCTAD: Developing Countries Have Opportunity to Attract Pharma Investment
20 Jun 2011
A report says the poorest countries in the world have an unprecedented opportunity to attract investment in the pharmaceutical sector.
Read more
Janssen Recalls Risperdal Tablets and Risperidone Tablets
20 Jun 2011
The recalls stem from two consumer reports of an uncharacteristic odor thought to be caused by trace amounts of TBA.
Read more
Boehringer Ingelheim Signs Deal with Zealand
20 Jun 2011
The agreement gives Boehringer Ingelheim global development and commercialisation rights to ZP2929, Zealand Pharma's lead glucagon/GLP-1 dual agonist drug candidate.
Read more